🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Renee Maria Saliby giving a spectacular talk on MADCAM-1 as a prognostic biomarker in #RCC. From mechanistic insights, levels of MADCAM-1 stratified by IMDC risk, survival based on treatment, to showing its predictive accuracy in survival outcomes. #ASCO25

💫ASCO #ASCO25 #IMGoncCOP meeting was so genuine, collaborative, and uplifting! 💎With >200 attendees and 20 presenters, we came together to share real experiences, emotional and logistical burdens of moving from abroad, guided the next generation on tackling challenges, and

Congrats to Dr.Jeremiah Wala, the first ASCO Dr.Felix Feng Endowed Young Investigator Awardee. Thanks to his friends and colleagues and Conquer Cancer, the ASCO Foundation for ensuring his legacy of creative science and a commitment to collaboration. Eric J. Small, MD, FASCO Eric Feng Nancy Lin, MD

🤔 Still thinking about the fantastic #KidneyCancer program from #ASCO25? 🎙️Join international panel of experts Alessandro Rametta 🇮🇹, Guillermo de Velasco 🇪🇸, Javier Puente 🇪🇸 as we discuss how impactful RCC data influences practice today and research tomorrow! 🔗 shorturl.at/yXAZr 👥

Want to catch up on #ASCO25 Kidney Cancer updates? Join ecancer roundtable in Renal cell Carcinoma: ecancer.org/en/video/12406… cc: ASCO Michael Serzan, MD Guillermo de Velasco

4 pictures aren’t enough to thank everyone who made this moment possible Sharing an ASCO oral with my co-mentor David Braun and other giants in the field during intern year was surreal Grateful for my Dana-Farber Lank Center for Genitourinary Oncology family, the 💩team, and the one and only Toni Choueiri, MD More

We’re so proud of you Renee Maria Saliby! You’re a shining late at Yale IM Traditional Residency Program and so thankful that Toni Choueiri, MD sent you our way and thankful that David Braun continues to mentor you Yale Cancer Center Smilow Cancer Hospital

Thanks Toni Choueiri, MD for interviewing with me on your son’s Birthday. Dr Choueiri is raising funds for the Pan-Mass Challenge - all funds go to research at Dana-Farber Thanks OncoDaily for providing this platform to discuss critical topics, in this episode we talk about ✅how Toni

Congratulations to Toni Choueiri, MD on being the recipient of a Doctorate Honoris Causa from The Lebanese University recognizing his outstanding achievements in Oncology.

Excited to see our work published in Clinical Cancer Research ! Real-world pts w/ mHSPC #prostatecancer w/ HRRalt had worse survival than those w/ non-altered HRR 👉bit.ly/3TsOw9i👇 Grateful for terrific support from team Ryon Graf, PhD Umang Swami Neeraj Agarwal, MD, FASCO UroToday.com OncoAlert

🚨 Our new study alert! Elsevier What is the role of comorbidity burden in response to immunotherapy based combos in patients with metastatic renal cell carcinoma? 🎯Endpoints : Overall surival and time to treatment failure High comorbidity 🟰 Worse Outcomes ❓❗️No

Our Dana-Farber Lank Center for Genitourinary Oncology and Signoretti Lab are looking for a junior pathologist/resident (at least 1 year of residency training) to join our group and lead one of our translational efforts in kidney cancer. Training in general pathology is ok as long as it is 6-12 months. Please

Delighted to share this news on the appointment of Professor Samra Turajlić as the Director of the CRUK Manchester Institute. Samra is an outstanding clinician scientist with a remarkable track record in cancer research. Her leadership will enable the Manchester Institute to continue to grow as

Proud of Elliott Miller, the winner of the Fred S. Kantor, MD, Award for Teacher of the Year at Yale New Haven Health System, for the second time! 👏🏽 Yale School of Medicine Yale Cardiology medicine.yale.edu/internal-medic…

Congrats to the ⁦National Cancer Institute⁩ Team on this landmark paper in HLRCC! It sets the SOC in this rare kidney cancer variant. ⁦NEJM⁩ ⁦NCI Surgical Oncology⁩ ⁦NCI CCR GU Malignancies⁩ nejm.org/doi/full/10.10…

After an injury sidelined his 8th PMC, Toni Choueiri, MD is showing us what it means to commit as a Reimagined Rider. He may be off the road, but he’s still driving impact—supporting Dana-Farber and riding with heart and determination. hubs.ly/Q03v3Mjz0

Great work from Chris Labaki BIDMC , led with Eddy Saad and #KatrineMadsen. Large team effort led together with Lisa Henske Brigham and Women's Hospital Sachet Ashok Shukla MD Anderson Cancer Center and Eli Van Allen and Toni Choueiri, MD Dana-Farber KidneyCAN Kidney Cancer COA - Chromophobe and Oncocytic Tumor Alliance OncLive.com

1/ Thrilled to share our work on Chromophobe RCC (ChRCC) and Renal Oncocytic Neoplasms (RONs) out Journal of Clinical Oncology !!! Incredibly thankful to my mentors David Braun Toni Choueiri, MD Eli Van Allen and all co-authors Dana-Farber BIDMC IM Residency Yale University Brigham and Women's Hospital Link: ascopubs.org/doi/10.1200/JC…

✨Grateful to be part of this incredible team and to work alongside patients and advocates who give true meaning to our work Toni Choueiri, MD David Braun KidneyCAN

Hello #MedX! I’m Denise Mourad, PGY-3 IM resident Central Michigan U.. Excited to apply for #CardiologyFellowship #CardioMatch #WomenInCardiology #Match2026! My work focuses on education, research, mentorship, and leadership. Looking forward to connecting with programs and peers!